Evidence map›Paper›PMID 41327074›Full record

ArticleBMC infectious diseases2025

Prevalence and associated factors of schistosomiasis among children and adolescents visiting Chitokoloki Mission Hospital of Zambezi District.

Martin Chakulya, David Chisompola, Nyondo Chawela, Hanzooma Hatwiko, Matenge Mutalange, Memory Ngosa, Geofrey Mupeta, Marshall C Mubanga, Lukundo Siame, Chipego Hajamba and 4 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Martin Chakulya *Department of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia. chakulyamartin1@gmail.com.
David Chisompola *Department of Pathology, Arthur Division Children's Hospital, Ndola, Zambia. d.chisompola@gmail.com.
Nyondo ChawelaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Hanzooma HatwikoDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Matenge MutalangeDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Memory NgosaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Geofrey MupetaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Marshall C MubangaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Lukundo SiameDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Chipego HajambaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Ebenezer BandaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Joreen P PoviaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.
Nzooma M Shimaponda-MataaDepartment of Biomedical Sciences, University of Zambia, Lusaka, Zambia.
Sepiso K MasengaDepartment of Pathology and Microbiology, School of Medicine and Health Sciences, Mulungushi University, Livingstone, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUrogenital schistosomiasis remains a major public health challenge among children and adolescents in sub-Saharan Africa. Data on prevalence and associated factors in Zambia are scarce. This study assessed the burden of Schistosoma haematobium infection and its correlates among 271 children and adolescents attending the outpatient department of Chitokoloki Mission Hospital, Northwestern Province.

methodsWe conducted a retrospective cross-sectional study of clinical records from January to March 2025. Systematic random sampling of files for participants aged 5-18 years captured sociodemographic data, water-contact behaviours, haematuria, haematological indices (haemoglobin, MCV, MCHC), deworming history, and prior schistosomiasis. Urine microscopy for S. haematobium eggs defined infection status. Categorical variables were compared by chi-squared test and medians by Wilcoxon rank-sum. Multivariable logistic regression identified independent predictors of infection (p < 0.05).

resultsThe median age was 13 years (IQR: 12-15); 58.3% were male. Overall prevalence of schistosomiasis was 25.8% (n = 70). Haematuria was present in 80.2% of infected versus 0.5% of uninfected participants (p < 0.0001). Infected children had lower median haemoglobin (11.3 g/dL vs. 11.9 g/dL; p = 0.0067) and MCHC (30.9 g/dL vs. 32.1 g/dL; p = 0.0022). Only 3.6% of previously dewormed children were infected compared with 49.2% of non-dewormed peers (p < 0.0001). In adjusted odds ratio (aOR) analyses, absence of deworming (aOR 37.8; 95% CI 5.78-247.4), absence of haematuria (aOR 0.0014; 95% CI 0.0001-0.011), and lower haemoglobin (aOR 0.69 per g/dL; 95% CI 0.48-0.99) remained independently associated with infection.

conclusionsThere is a significant burden of urogenital schistosomiasis among school-aged children and adolescents attending Chitokoloki Mission Hospital in Zambezi District, Zambia. Targeted praziquantel distribution, cost-effective school-based urine screening in high endemic areas, awareness campaigns to sensitize the community on transmission and reinfections and the integration of nutritional and anaemia management strategies are critical components for effective disease control. Strengthening these interventions is essential to advance progress toward achieving the World Health Organization's 2030 schistosomiasis elimination targets in Zambia. CLINICAL TRIAL NUMBER: Not applicable (N/A).

Indexed as

SchistosomiasisSchistosomiasis haematobiaAdolescentAnimalsChildChild, PreschoolCross-Sectional StudiesFemaleHematuriaHumansMalePrevalenceRetrospective StudiesRisk FactorsSchistosoma haematobiumChildrenPrevalenceSchistosomiasisUrogenital infectionZambia

Identifiers

PMID41327074
PMCPMC12777193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.